Home › Funds › CAUSEWAY CAPITAL MANAGEMENT LLC › ZBH

CAUSEWAY CAPITAL MANAGEMENT LLC position in ZBH

ZIMMER BIOMET HOLDINGS INC · Health Care

CAUSEWAY CAPITAL MANAGEMENT LLC reported holding 412,776 shares of ZBH (ZIMMER BIOMET HOLDINGS INC) in its Q3 2026 13F filing — a position valued at US$36.7M, representing 0.41% of its reported portfolio and ranking #45 among its reported holdings. CAUSEWAY CAPITAL MANAGEMENT LLC has disclosed ZBH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)412.78K sh
Reported value held$36.67M
Portfolio Weight0.41%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How CAUSEWAY CAPITAL MANAGEMENT LLC's ZBH position evolved

CAUSEWAY CAPITAL MANAGEMENT LLC first disclosed a stake in ZBH in Q3 2023 at 405,863 shares (US$45.5M). The position peaked in Q1 2025 at 805,509 shares, worth US$91.2M. Across 13 filings, CAUSEWAY CAPITAL MANAGEMENT LLC increased the stake 7 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 412,776 shares valued at US$36.7M — a reduction of -376,034 shares quarter over quarter.. Notable position changes include a 39% increase in Q4 2023 (shares rose 8% over the following quarter), a 31% increase in Q2 2024 (shares were roughly flat over the following quarter), a 48% trim in Q3 2026 (shares rose 21% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 405.86K $45.55M New
Q4 2023 564.67K $68.72M Add
Q1 2024 506.25K $66.85M Reduce
Q2 2024 660.81K $71.72M Add
Q3 2024 794.29K $85.74M Add
Q4 2024 769.93K $81.33M Reduce
Q1 2025 805.51K $91.17M Add
Q2 2025 578.24K $52.74M Reduce
Q3 2025 581.78K $57.31M Add
Q4 2025 728.50K $65.51M Add
Q1 2026 808.11K $73.07M Add
Q2 2026 788.81K $67.91M Reduce
Q3 2026 412.78K $36.67M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ZBH and 13F data

ZBH (ZIMMER BIOMET HOLDINGS INC) is a Health Care company. 18 other funds we track also report a position in ZBH — the largest reported positions include Dodge & Cox (US$2.08B), DODGE & COX (US$2.08B), Harris Associates (Oakmark) (US$1.10B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ZBH

All ZBH fund holders →

FAQ

How long has CAUSEWAY CAPITAL MANAGEMENT LLC held ZBH?

CAUSEWAY CAPITAL MANAGEMENT LLC has disclosed ZBH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is CAUSEWAY CAPITAL MANAGEMENT LLC's current position in ZBH?

As of Q3 2026, CAUSEWAY CAPITAL MANAGEMENT LLC holds 412.78K shares of ZBH (ZIMMER BIOMET HOLDINGS INC), valued at $36.67M, representing 0.41% of its reported portfolio and ranking #45.

Has CAUSEWAY CAPITAL MANAGEMENT LLC been buying or selling ZBH?

In the latest 13F filing (Q3 2026), CAUSEWAY CAPITAL MANAGEMENT LLC reduced its position in ZBH. The position peaked in Q1 2025 at 805.51K shares.

Which other funds hold ZBH?

Other major institutional holders of ZBH include Dodge & Cox, DODGE & COX, Harris Associates (Oakmark), among 18 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.